IBDEI1BK ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23367,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,23367,2)
 ;;=^334256
 ;;^UTILITY(U,$J,358.3,23368,0)
 ;;=346.90^^125^1406^54
 ;;^UTILITY(U,$J,358.3,23368,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23368,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,23368,1,5,0)
 ;;=5^Migraine
 ;;^UTILITY(U,$J,358.3,23368,2)
 ;;=^336879
 ;;^UTILITY(U,$J,358.3,23369,0)
 ;;=723.1^^125^1406^57
 ;;^UTILITY(U,$J,358.3,23369,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23369,1,4,0)
 ;;=4^723.1
 ;;^UTILITY(U,$J,358.3,23369,1,5,0)
 ;;=5^Neck Pain
 ;;^UTILITY(U,$J,358.3,23369,2)
 ;;=^21917
 ;;^UTILITY(U,$J,358.3,23370,0)
 ;;=607.84^^125^1406^53
 ;;^UTILITY(U,$J,358.3,23370,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23370,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,23370,1,5,0)
 ;;=5^Male Erectile Disorder
 ;;^UTILITY(U,$J,358.3,23370,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,23371,0)
 ;;=173.99^^125^1406^83
 ;;^UTILITY(U,$J,358.3,23371,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23371,1,4,0)
 ;;=4^173.99
 ;;^UTILITY(U,$J,358.3,23371,1,5,0)
 ;;=5^Skin Cancer NOS
 ;;^UTILITY(U,$J,358.3,23371,2)
 ;;=^340493
 ;;^UTILITY(U,$J,358.3,23372,0)
 ;;=278.01^^125^1406^55
 ;;^UTILITY(U,$J,358.3,23372,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23372,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,23372,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,23372,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,23373,0)
 ;;=585.6^^125^1406^34
 ;;^UTILITY(U,$J,358.3,23373,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23373,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,23373,1,5,0)
 ;;=5^End Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,23373,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,23374,0)
 ;;=482.1^^125^1406^81
 ;;^UTILITY(U,$J,358.3,23374,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23374,1,4,0)
 ;;=4^482.1
 ;;^UTILITY(U,$J,358.3,23374,1,5,0)
 ;;=5^Pseudomonal Pneumonia
 ;;^UTILITY(U,$J,358.3,23374,2)
 ;;=^269932
 ;;^UTILITY(U,$J,358.3,23375,0)
 ;;=482.2^^125^1406^37
 ;;^UTILITY(U,$J,358.3,23375,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23375,1,4,0)
 ;;=4^482.2
 ;;^UTILITY(U,$J,358.3,23375,1,5,0)
 ;;=5^H. Influenzae Pneumonia
 ;;^UTILITY(U,$J,358.3,23375,2)
 ;;=^269933
 ;;^UTILITY(U,$J,358.3,23376,0)
 ;;=482.84^^125^1406^50
 ;;^UTILITY(U,$J,358.3,23376,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23376,1,4,0)
 ;;=4^482.84
 ;;^UTILITY(U,$J,358.3,23376,1,5,0)
 ;;=5^Legionnaires' Disease
 ;;^UTILITY(U,$J,358.3,23376,2)
 ;;=^68817
 ;;^UTILITY(U,$J,358.3,23377,0)
 ;;=482.9^^125^1406^17
 ;;^UTILITY(U,$J,358.3,23377,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23377,1,4,0)
 ;;=4^482.9
 ;;^UTILITY(U,$J,358.3,23377,1,5,0)
 ;;=5^Bacterial Pneumonia NOS
 ;;^UTILITY(U,$J,358.3,23377,2)
 ;;=^12347
 ;;^UTILITY(U,$J,358.3,23378,0)
 ;;=430.^^125^1406^88
 ;;^UTILITY(U,$J,358.3,23378,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23378,1,4,0)
 ;;=4^430.
 ;;^UTILITY(U,$J,358.3,23378,1,5,0)
 ;;=5^Subarachnoid Hemorrhage
 ;;^UTILITY(U,$J,358.3,23378,2)
 ;;=^114989
 ;;^UTILITY(U,$J,358.3,23379,0)
 ;;=434.91^^125^1406^24
 ;;^UTILITY(U,$J,358.3,23379,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23379,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,23379,1,5,0)
 ;;=5^Crb Art Occl,Unspec w/ CRB Inf
 ;;^UTILITY(U,$J,358.3,23379,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,23380,0)
 ;;=431.^^125^1406^47
 ;;^UTILITY(U,$J,358.3,23380,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23380,1,4,0)
 ;;=4^431.
 ;;^UTILITY(U,$J,358.3,23380,1,5,0)
 ;;=5^Intracerebral Hemorrhage
 ;;^UTILITY(U,$J,358.3,23380,2)
 ;;=^64977
 ;;^UTILITY(U,$J,358.3,23381,0)
 ;;=432.1^^125^1406^89
 ;;^UTILITY(U,$J,358.3,23381,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI1BK
